Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace B. Vergote, Whitney A. Spannuth Graybill, Domenica Lorusso, Colleen McCormick and 12 more
- Rank
- 6 of 474
- Percentile
- top 1.3%
- Where
- European Journal of Cancer, 2023
- Citations
- 119
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.